National Healthcare Group’s Post

Associate Professor Tey Hong Liang, from National Skin Centre and Associate Professor Timothy Tan, from Nanyang Technological University invented the world's first RNA based scar prevention patch. The secret lies in siRNA (gene silencing RNA), a candidate for treating diseases that lack effective therapies. Both inventors ingeniously embedded the unstable siRNA into dissolving microneedles, allowing painless transdermal delivery. The product, Renectin Antiscar, has been clinically tested and the results are promising: - 88% of users prefer Renectin over silicone gel sheets after using them for 60 days. - 84% of users observed scar volume reduction within the same period. Imagine the impact it will have on patients with scars from surgeries, injuries, or skin. Hong Liang TEY Benjamin Seet Cher Heng Tan Louis Ang Centre for Medical Technologies and Innovations (CMTi) Hannah Chong Heiny Tan Timothy Tan Jack Wong Amanda Kooi National Healthcare Group

Excagol medtech in collaboration with the HSBA Hamburg School of Business Administration is thrilled to announce research findings that are set to transform the field of Venipuncture. Our scientific study "Analysis and Comparison of Costs and Market Success of Different Venipuncture Methods," led by Bishara Abukhadra, offers critical insights into the efficacy and economic impact of excagol’s innovative Electronic Venipuncture Apparatus (EVA). Key Findings and Impact: Cost Efficiency and Market Readiness: The study thoroughly analyzed various venipuncture methods, comparing them against excagol’s EVA. The results were enlightening - EVA not only promises a reduction in the healthcare providers' operational costs but also enhances procedural efficiency. Our technology ensures a higher success rate on the first attempt, thus minimizing discomfort and time spent per patient. Innovative Technology: EVA is designed to be more than just a tool; it is a leap toward safer, faster, and less painful venipuncture procedures. With capabilities that significantly lower the need for multiple puncture attempts, EVA is an innovation in medical technology. Strategic Market Positioning: The competitive analysis provided by the research positions excagol at the forefront of the advanced venipuncture solutions market. The insights derived from the study are instrumental in tailoring our market entry strategies and distinguishing our offerings from competitors. This collaboration with HSBA has reinforced excagol’s commitment to advancing healthcare technology and showcased our ability to lead in a competitive market environment. By integrating feedback from healthcare professionals and focusing on continuous improvement, excagol is set to redefine standards in patient care and operational efficiency.

After #AusMedtech2024, what's next for our sector? The Australian medical technology ecosystem is flourishing, covering nearly 600 companies and boasting the highest rate of growth in life sciences according to AusBiotech research. But that doesn't mean the work is over – one of the major takeaways from AusMedtech 2024 is that the medtech innovation system is disconnected and fragmented. A national approach to medtech that pools resources and speaks in a single voice to government is a top priority, helping connect people and facilities to enable innovation across the sector. As a voice to industry, the VMH has a role to play in this too, collaborating with our colleagues at AusBiotech, the Medical Technology Association of Australia (MTAA), ANDHealth, The Australian National Fabrication Facility (ANFF), the Medical Device Partnering Program, and BioMelbourne Network to help unify the sector. We already have the infrastructure, skills, technical expertise, and training resources necessary to accelerate medtech in Australia, it's just about getting it into the right hands. The VMH is helping to bridge this gap through our Navigator initiative, connecting government, academia, and businesses to better make use of our state’s amazing medtech capabilities. Learn more about the work we're doing to support our medtech sector: https://lnkd.in/gEDXBtRF

What does the future look like for medtech as we enter a new era of sustainbility and how do you take the first step on your green journey? Join us tomorrow at #MedtechRising to find out from Croom Medical and more. https://lnkd.in/eQVw6d3Y

Interested in integrated skincare? This new webinar series is for you.

🚀 Navigating Growth in the MedTech Sector at #Sachs_EHTF! Join us for the "Meeting the Challenges of Medtech & Device Growth Companies Panel" on February 27th, 2024, at the Hilton Zurich Airport Hotel. Unveil the strategies for overcoming hurdles and seizing opportunities in the rapidly evolving MedTech landscape. 🛠️💡 Chaired by: Cornelia Jahnel, Head Investor Relations, biosaxony Management GmbH Panellists: Andre Hofmann, CEO, biosaxony Management GmbH Matt Sagan, MBA, SVP, Chief Operating Officer, SDS Optic Inc. Sebastian Alexander, CEO, VivoSensMedical GmbH Steve Kappenthuler, Co-Founder & CBO, MUVON Therapeutics AG This session will delve into the complex challenges facing MedTech and medical device companies in their growth phase, including regulatory pathways, market access, and innovation scaling. Hear from seasoned industry leaders on how to successfully navigate these challenges, capitalize on technological advancements, and drive sustainable growth in a competitive market. Whether you are an emerging MedTech entrepreneur, an investor interested in the latest growth strategies, or a professional seeking to understand the future of medical technology, this panel is your opportunity to learn from the best in the business. Join us #inperson or #online to be at the forefront of MedTech innovation. Secure your spot now by registering at www.sachsforum.com/5ehtf. #EHTF2024 #HealthTech #DigitalHealth #MedTech #MedicalDevices #HealthcareInnovation #GrowthStrategies #MarketAccess #RegulatoryChallenges #InnovationInHealthcare #MedTechGrowth #MedicalTechnology #HealthcareSector #InvestinMedTech #SachsSpringLifeSciencesWeek #SSLSW

Best of luck to our regional finalists who are shortlisted in the Medilink UK National Healthcare Business Awards, taking place on 11 July at the London Institute for Healthcare Engineering. 🎉 Our Business Awards took place last May, and some of the winners have now been put forward as finalists in our Medilink network’s nationwide awards for the following categories: Advances in Digital Healthcare ⭐ Black Space Technology Delivering Innovation into Health and Care ⭐ Cytecom Export Achievement ⭐ Cellomatics Biosciences Ltd Innovation ⭐ Bioxhale Outstanding Achievement ⭐ Upperton Pharma Solutions Partnership Between Academia and Business  ⭐ Healthcare Technologies Institute, University of Birmingham and Salts Healthcare Start Up ⭐ MESOX From exporting success, innovative business ideas to advancements in digital healthcare, the Medilink UK Awards recognise a multitude of achievements and outstanding contributions to the medtech and life sciences sector nationwide. Read more here >>> https://lnkd.in/eVejsqDY #businessawards #healthcare #medtech #lifesciences #innovation

ZiP Diagnostics welcomes the launch of the Medical Science Co-Investment Plan, identifying key investment opportunities in medical devices, complex therapeutics, digital health, and sustainability. Industry and Science Minister Ed Husic MP and Health and Aged Care Minister Mark Butler MP have unveiled the first of seven plans, showcasing a deep understanding of sector drivers and market needs. We support the plan which aims to drive the development of manufacturing in Australia in the medical science sector by increasing industrial capabilities and capacity, supporting the commercialisation of high-value products, and improving the international competitiveness of the medical science and technology sector. We’re also behind the move to improve supply chain diversification to ensure resilience to disruption. ZiP is proudly local in every way. Based in Melbourne, we operate state-of-the-art laboratory and production facilities and all manufacturing is conducted in-house. We're committed to driving innovation and making a meaningful impact in these critical areas. #MedicalScience #InvestmentOpportunities #HealthcareInnovation #GovernmentInitiative #StrategicInvestments #HealthcareTransformation #Innovation #HealthSecurity #AgTech #AdvancedManufacturing #AI #Biotechnology

Last call for submitting your work for the #MimicsInnovationAward Advance Mass Personalization for Healthcare Mass personalization is about delivering truly individual medicine. It has the potential to change the lives of millions of people around the world. The Mimics Innovation Awards celebrate those driving this shift and transforming healthcare. 🏥✨ Entering the Mimics Innovation Awards is simple and fast: just fill in a short form and upload your paper. Follow the link below to check out the rules and regulations and submit your research. #HealthcareInnovation #MassPersonalization #MimicsInnovationAwards #MedicalResearch #PersonalizedMedicine #academia #hospitals #biomedical